{"prompt": "['Item', 'Grade 1 Toxicity', 'Grade 2 Toxicity', 'Grade 3 Toxicity', 'Grade 4 Toxicity', 'Constipation', 'Mild', 'Moderate', 'Severe', 'Distensions w/vomiting', 'Transient 3-4 loose', 'Orthostatic hypotension', 'Hypotensive shock or', 'Diarrhea', '5-7 loose stools/day', 'or > 7 loose stools/day or', 'hospitalization for IV fluid', 'stools/day', 'required IV fluids', 'therapy required', 'NEURO AND NEUROMUSCULAR', 'Intention tremor,', 'Neuro-cerebellar', 'Slight incoordination', 'dysmetria, slurred speech;', 'Locomotor ataxia', 'Incapacitated', 'dysdiadochokinesis', 'nystagmus', 'Moderate anxiety or', 'Severe anxiety or', 'Acute psychosis;', 'Mood', 'Mild anxiety or depression', 'depression and therapy', 'depression or mania;', 'incapacitated, requires', 'required', 'needs assistance', 'hospitalization', 'Mild difficulty', 'Moderate', 'concentrating; no Rx; mild', 'confusion/agitation some', 'Severe confusion/agitation', 'Neuro control', 'needs assistance for ADL;', 'Toxic psychosis;', 'confusion/agitation; ADL', 'limitation of ADL; minimal', 'hospitalization', 'unaffected', 'Rx', 'therapy required', 'Mild objective', 'Muscle strength', 'Subjective weakness no', 'signs/symptoms no', 'Objective weakness', 'objective symptoms/signs', 'function limited', 'Paralysis', 'decrease in function', 'OTHER PARAMETERS', '37.7-38.5\u00b0C or', '38.6-39.5\u00b0C or', '39.6-40.5\u00b0C or', 'Fever: oral, > 12 hours', '> 40.5\u00b0C or > 104.9\u00b0F', '99.9-101.3\u00b0F', '101.4-103.1\u00b0F', '103.2-104.9\u00b0F', 'Headache', 'Transient, moderate;', 'Severe; responds to initial', 'Mild, no Rx therapy', 'Intractable; required', 'Rx required', 'narcotic therapy', 'repeated narcotic therapy', 'Normal activity', 'Fatigue', 'No decrease in ADL', 'Normal activity decreased', \"decreased > 50% can't\", 'Unable to care for self', '25-50%', 'work', 'Generalized urticaria;', 'Allergic reaction', 'Pruritus without rash', 'Localized urticaria', 'angioedema', 'Anaphylaxis', 'Induration < 10 cm or', 'Induration 10 cm or', 'Local Reaction', 'Tenderness or erythema', 'Necrosis', 'phlebitis or inflammation', 'ulceration', 'Emicizumab - F. Hoffmann-La Roche Ltd', '172 / Protocol MO39129, Version 3']['Item', 'Grade 1 Toxicity', 'Grade 2 Toxicity', 'Grade 3 Toxicity', 'Grade 4 Toxicity', 'Exfoliative dermatitis,', 'mucous membrane', 'Diffuse, maculo-papular', 'Vesiculation, moist', 'Mucocutaneous', 'involvement or erythema,', 'Erythema; pruritus', 'rash, dry desquamation', 'desquamation, or', 'ulceration', 'multiforme or suspected', 'Stevens-Johnson or', 'necrosis requiring surgery', 'ADL=activities of daily living; ALT=alanine aminotransferase; aPTT=activated partial thromboplastin time; AST=aspartate aminotransferase; BUN=blood', 'urea', 'nitrogen; ECG=electrocardiogram; FEV1=forced expiratory volume in 1 second; GGT=gamma glutamyl transferase; IV=intravenous; LLN=lower limit', 'or', 'normal; PT=prothrombin time; Rx=treatment; SGOT=serum glutamic oxaloacetic transaminase; SGPT=serum glutamic pyruvic transaminase; ULN=upper', 'limit of normal; WHO=World H', 'Emicizumab - F. Hoffmann-La Roche Ltd', '173 / Protocol MO39129, Version 3']\n\n###\n\n", "completion": "END"}